Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 EUR | -0.71% | -3.47% | -65.25% |
Sales 2024 * | 650K 695K 950K | Sales 2025 * | 31.4M 33.57M 45.9M | Capitalization | 49.91M 53.37M 72.96M |
---|---|---|---|---|---|
Net income 2024 * | -20M -21.38M -29.23M | Net income 2025 * | -1M -1.07M -1.46M | EV / Sales 2024 * | 150 x |
Net Debt 2024 * | 47.5M 50.79M 69.43M | Net Debt 2025 * | 17.7M 18.93M 25.87M | EV / Sales 2025 * | 2.15 x |
P/E ratio 2024 * |
-2.36
x | P/E ratio 2025 * |
-27.8
x | Employees | 62 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.24% |
Latest transcript on Sequana Medical N.V.
1 day | -0.71% | ||
1 week | -3.47% | ||
Current month | -7.64% | ||
1 month | -14.20% | ||
3 months | -59.12% | ||
6 months | -48.90% | ||
Current year | -65.25% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 15-12-31 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 22-07-18 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 18-11-07 |
Ids van der Weij
BRD | Director/Board Member | - | 11-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.39 | -0.71% | 45,796 |
24-04-25 | 1.4 | 0.00% | 17,476 |
24-04-24 | 1.4 | -1.06% | 17,617 |
24-04-23 | 1.415 | -1.05% | 44,506 |
24-04-22 | 1.43 | -0.69% | 22,362 |
Real-time Euronext Bruxelles, April 26, 2024 at 10:57 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.25% | 53.29M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SEQUA Stock